Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis

LC García-Carnero, HM Mora-Montes - Journal of Fungi, 2022 - mdpi.com
The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high
mortality and morbidity among patients with comorbidities. This viral infection promotes the …

New insights on mucormycosis and its association with the COVID-19 pandemic

MG Alshahawey, GS El-Housseiny… - Future science …, 2022 - Taylor & Francis
COVID-19 continues to cause significant fatality worldwide. Glucocorticoids prove to play
essential roles in COVID-19 management; however, the extensive use of steroids together …

[HTML][HTML] Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review

NN Shah, Z Khan, H Ahad, AY Elderdery… - Journal of infection and …, 2022 - Elsevier
Abstract As of 25th July, 2022, global Disease burden of 575,430,244 confirmed cases and
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …

[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach

A Azhar, WH Khan, PA Khan, K Alhosaini… - Journal of Infection and …, 2022 - Elsevier
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …

Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic

A Sharma, A Goel - Folia Microbiologica, 2022 - Springer
Mucormycosis is a deadly opportunistic disease caused by a group of fungus named
mucormycetes. Fungal spores are normally present in the environment and the immune …

COVID19 associated mucormycosis: A review

PR Palanisamy, D Elango - … of Family Medicine and Primary Care, 2022 - journals.lww.com
Mucormycosis, a rare fungal disease has emerged as a new epidemic in India, during the
CoronaVirus Disease 2019 (COVID-19) pandemic. Mucormycosis is caused by the …

[HTML][HTML] Coronavirus disease-associated mucormycosis from a tertiary care hospital in India: a case series

Y Singh, V Ganesh, S Kumar, N Patel, R Aggarwala… - Cureus, 2021 - ncbi.nlm.nih.gov
Background: Coronavirus disease (COVID-19) remains a health concern with new
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …

[HTML][HTML] Post-Covid alliance-mucormycosis, a fatal sequel to the pandemic in India

M Nambiar, SR Varma, M Damdoum - Saudi Journal of Biological Sciences, 2021 - Elsevier
As the battle against the deadly Covid-19 pandemic is still continuing worldwide, several
complications are being reported in patients who have recovered post-covid. One such …

COVID-19-associated mucormycosis: A review of an emergent epidemic fungal infection in the era of COVID-19 pandemic

V Chamola, R Mohammadi, H Nair… - Journal of Research …, 2022 - journals.lww.com
At a time when the COVID-19's second wave is still picking up in countries like India, a
number of reports describe the potential association with a rise in the number of cases of …

The double trouble: COVID-19 associated mucormycosis a focused review and future perspectives

AK Agnihotri, M Vij, OI Aruoma, VD Yagnik… - Global Journal of …, 2021 - gjmpbu.org
Mucormycosis, a deadly fungal infection, has affected thousands of COVID-19 patients in
India. Mucormycosis, formerly known as zygomycosis, is caused by the many fungi that …